K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
<p><strong>Background</strong></p> Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Mya...
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
BioMed Central
2016
|